Accessibility Statement Skip Navigation
  • Resources
  • Blog
  • Journalists
  • +44 (0)20 7454 5110
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All Public Company News
      • All Multimedia News
      • View All News Releases

      • Regulatory News

      • D/A/CH Regulatory News
      • UK Regulatory News
      • View All Regulatory News

  • Business & Money
      • Auto & Transportation

      • Aerospace & Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads & Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking & Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers & Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalisation
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls & Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil & Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defence
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation & Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking & Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers & Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines & Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics & Personal Care
      • Fashion
      • Food & Beverages
      • Furniture & Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewellery
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks & Tourist Attractions
      • Gambling & Casinos
      • Hotels & Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Animal Welfare
      • Corporate Social Responsibility
      • Economic News, Trends & Analysis
      • Education
      • Environmental
      • European Government
      • Labour & Union
      • Natural Disasters
      • Not For Profit
      • Public Safety
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Overview
  • Distribution
  • Paid Placement
  • Multichannel Amplification
  • Disclosure Services
  • SocialBoost
  • Rooms
    • MediaRoom
    • ESG Rooms
  • AI Tools
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Hamburger menu
  • Cision PR Newswire UK provides press release distribution, targeting, monitoring, and marketing services
  • Send a Release
    • Phone

    • +44 (0)20 7454 5110 from 8 AM - 5:30 PM GMT

    • ALL CONTACT INFO
    • Contact Us

      +44 (0)20 7454 5110
      from 8 AM - 5:30 PM GMT

  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • News in Focus
    • Browse News Releases
    • Regulatory News
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
    • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • Overview
  • Distribution
  • Paid Placement
  • Multichannel Amplification
  • Disclosure Services
  • Cision Communications Cloud®
  • AI Tools
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists

Pain: Consumption of Opioid Drugs in Southern Europe up by 15%. New Aspects Discussed at the Closing Sessions of the World Medicine Park in Minorca


News provided by

World Medicine Park

12 May, 2014, 11:00 GMT

Share this article

Share toX

Share this article

Share toX

MAHON, Minorca, May 12, 2014 /PRNewswire/ --

Today marks the final sessions of the congress of the World Medicine Park, the first global forum devoted to medical sciences, this year focusing on dealing with pain. Innovative aspects discussed at the congress include the future of analgesic therapy based on genetic medicine for increasingly personalized cures. Jordi Moya Riera, President of the congress: "Make a date for next year's edition which will be even richer with more attendees and multidisciplinary aspects. Our heartfelt thanks to the Institutions of Minorca and the Balearic Islands for their unstinting support." 

More than 1,200 delegates from several European countries came together for the first edition of the World Medicine Park, which opened on 7 May in Minorca. Not just a congress but a multidisciplinary medicine park which aims to become a meeting place for the world's healthcare community.

"What we have seen over these days was an intense period of sharing and teamwork involving clinical specialists, researchers, companies and Institutions to discuss the major challenge of pain," says Guido Fanelli, Professor of Anesthesiology and Reanimation at the University of Parma, amongst the main supporters of the WMP. "Everything took place with the backing of high technology and innovation. One of the main conclusions of the congress was the need to improve patients' understanding of opioid analgesics so that these substances become more accepted throughout Europe; and the training of clinical specialists is also important so that they are able to prescribe the most appropriate cures. Regarding the use of opioid analgesics, there has been a double-digit growth of consumption in Southern European countries, higher than levels in Northern countries, but there is still a gap to be filled."  

Regarding current pharmacological prescriptions, there was an interesting round table with the participation of two leading companies in the field of pain therapy, Grünenthal and Mundipharma, represented by the two Regional Managers for Southern Europe, Thilo Stadler, who illustrated the market data for Europe, and Marco Filippini, who presented the data for Italy. Regarding the situation illustrated by Stadler, the number of Patient Treatment Days (PTDs) per year shows a positive trend with a slow but constant increase in appropriate therapies in Southern Europe. During the period 2009-2013, Italy, France, Spain and Portugal showed an overall increase of 15% in the consumption of strong opioid drugs, against +8% in Northern European countries, where the use of these substances is anyway higher. In more detail, according to IMS data for January-December 2013, first place is held by Denmark (9.1 PTDs), followed by UK (8.1) and Sweden (5.8); at the opposite end of the classification, Spain (2.4), France (2), Italy (1.3) and Portugal (0.5). Moreover, the market for strong opioid analgesics in 2013 stood at 1.8 billion euros, showing +10% for Southern Europe, against +3% for Northern Europe. The figures given by Filippini showed that there has been a slight improvement in Italy regarding appropriate prescriptions for pain treatment, although non-steroidal anti-inflammatory drugs (NSAIDs) remain by far the most purchased self-medication OTC drugs, despite significant side effects.

A significant contribution to the discussion came from a representative of the United Nations who confirmed the UN commitment to support the use of opioid analgesics against pain. "About 83% of the world's population has little or no access to narcotic substances for pain therapy," said Gilberto Gerra, from the United Nations Office of Drugs and Crime (UNODC), one of the speakers at the World Medicine Park. "Every year there are 5.5 million terminal cancer patients without adequate control of suffering. Today the United Nations reiterate clearly that the controlled provision of narcotic substances should be guaranteed in order to comply with international conventions. We are working on the full revision of the Model Law  regarding access to medicines and preventing problems of illegality, through new and advanced provisions, aimed less at punishing offenders and more at curing, protecting and supporting patients. By the end of 2014 we shall have a final version to submit to member States so that they can review their own national legislation in the light of these provisions."

The congress also examined the interesting subject of personalized genetic medicine, since there are development prospects for pain therapy. "An example is low back pain which concerns 80% of patients with chronic algic conditions," says Massimo Allegri, Medical Specialist for Pain Therapy, Polyclinic of San Matteo, Pavia. "Many studies show that, in half the cases, this condition is of hereditary origin. The use of genetics will help us to identify people with the biomarkers that expose them to the risk of developing certain neuralgic conditions, enabling us to prevent and cure them in a more targeted manner. This has considerable social and economic importance since, with an aging population, in twenty years time our current healthcare systems will no longer be sustainable. Faced by limited resources, we need therapies that are ever more tailor-made."

"We trust that the World Medicine Park will continue to grow in the coming years with an increasing number of medical specializations interacting with one another while maintaining their individuality and high scientific value," said Jordi Moya Riera, President of the congress and the World Health Association. "For the 2015 edition, our invitation extends to all thea ctors of the healthcare community, working together to create a new medical sciences park that is even larger with more attendees as well as multidisciplinary aspects. Our sincere thanks to the Institutions of Minorca and the Balearic Islands for the unstinting support they have given to this event."

Modal title

Contact PR Newswire

  • +44 (0)20 7454 5110
    from 8 AM - 5:30 PM GMT
  • General Enquiries
  • Media Enquiries
  • Partnerships

Products

  • Content Distribution
  • Multimedia Services
  • Disclosure Services
  • Cision Communications Cloud®

About

  • About PR Newswire
  • About Cision
  • Partnering Opportunities
  • Careers
  • Accessibility Statement
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United States
  • Vietnam

My Services

  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
  • Data Privacy

Do not sell or share my personal information:

  • Submit via Privacy@cision.com 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
+44 (0)20 7454 5110
from 8 AM - 5:30 PM GMT
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 PR Newswire Europe Limited. All Rights Reserved. A Cision company.